Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

Nagel, BHP; Neudorf, U; Hanssler, L; Kuhn, U; Schmaltz, AA.
Problems of therapy of fetal life-threatening dysrhythmias
MONATSSCHR KINDERHEILK. 2000; 148(7): 666-672. Doi: 10.1007/s001120050614
Web of Science FullText FullText_MUG

Leading authors Med Uni Graz: Nagel Bert Hermann Philipp
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: Fetal supraventricular tachycardia acid atrial flutter are life-threatening dysrhythmias, which, untreated, may ca use non-immune fetal hydrops and may lead to fetal death. In the literature optimal management and the way of antiarrhythmic maternal and more recently fetal drug therapy remains controversial. The aim of this article is to report on the problems of thera py of feta I tachyarrhythmias and to summarize current knowledge. After diagnosing the arrhythmia with the help of M mode or doppler echocardiography perinatologists, neonatologists and pediatric cardiologists have to decide on the further proceedings individually. The fetus without signs of hydrops can often be treated successfully with digoxin administered to the mother. In fetuses with tachycardia-induced hydrops digoxin is the drug of first choice, too. They, however, need significantly mo re antiarrhythmic drugs and longer therapy for cardioversion into sinusrhythm, which is achieved less frequently than in fetuses with out hydrops. In hydrops patients a further option is direct fetal therapy with drug application into the umbilical vein. Longterm prognosis seems to be excellent regardless of the severity of illness at clinical presentation.
Find related publications in this database (Keywords): fetal tachyarrhythmia; electrophysiology; antiarrhythmic drug therapy; non-immune hydrops fetalis